Enzymatica AB (STU:EN9) FCF Margin %: -59.70% (As of Mar. 2026)

What is Enzymatica AB FCF Margin %?

Enzymatica AB STU:EN9 +11.80% 58 FCF Margin % is -59.70% as of Mar. 2026. GuruFocus rates STU:EN9 with a GF Score™ of 58/100 and a GF Value™ of €0.16. The stock has 2 warning signs investors should review. Among 958 Drug Manufacturers companies, Enzymatica AB ranks worse than 91.23% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Enzymatica AB's Free Cash Flow for the three months ended in Mar. 2026 was €-0.63 Mil. Enzymatica AB's Revenue for the three months ended in Mar. 2026 was €1.06 Mil. Therefore, Enzymatica AB's FCF Margin % for the quarter that ended in Mar. 2026 was -59.70%.

As of today, Enzymatica AB's current FCF Yield % is -6.66%.

The historical rank and industry rank for Enzymatica AB's FCF Margin % or its related term are showing as below:

STU:EN9' s FCF Margin % Range Over the Past 10 Years
Min: -143.42 Med: -74.91 Max: -13.92
Current: -75.18

During the past 13 years, the highest FCF Margin % of Enzymatica AB was -13.92%. The lowest was -143.42%. And the median was -74.91%.

STU:EN9's FCF Margin % is ranked worse than
91.23% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2.445 vs STU:EN9: -75.18

Enzymatica AB FCF Margin % Related Terms

Enzymatica AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for Enzymatica AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzymatica AB FCF Margin % Chart

Enzymatica AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

-73.37

-139.51

-80.58

-133.62

-76.44

Enzymatica AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-69.58	-257.98	-82.11	2.26	-59.70

STU:EN9 vs ZTS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Enzymatica AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzymatica AB FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzymatica AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Enzymatica AB's FCF Margin % falls into.

Save Embed

58GF Score

Enzymatica AB STU:EN9

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Enzymatica AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Enzymatica AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-3.786	/	4.953
	=	-76.44 %

Enzymatica AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-0.634	/	1.062
	=	-59.70 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -59.70% mean?

Enzymatica AB (STU:EN9) has a FCF Margin % of -59.70% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Enzymatica AB and its competitors. According to the industry distribution chart, Enzymatica AB ranks #874 out of 958 companies in the Drug Manufacturers industry, placing it in the top 91.2%.

Is Enzymatica AB's FCF Margin % too high?

Enzymatica AB's current FCF Margin % is -59.70%. Based on the distribution chart, Enzymatica AB ranks #874 out of 958 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Enzymatica AB has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.

How does Enzymatica AB's FCF Margin % compare to ZTS?

According to the Drug Manufacturers industry distribution chart, Enzymatica AB ranks #874 out of 958 companies for FCF Margin %. This places Enzymatica AB in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Drug Manufacturers company?

The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Enzymatica AB and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enzymatica AB's current FCF Margin % is -59.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Enzymatica AB stock overvalued right now?

Enzymatica AB (STU:EN9) has a current FCF Margin % of -59.70%. The stock's GF Value™ is €0.16, compared to a current price of €0.20 — trading 24.4% above its estimated fair value. The current FCF Margin % is -59.70%. Enzymatica AB's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Enzymatica AB (STU:EN9), the current FCF Margin % is -59.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enzymatica AB (STU:EN9) Overvalued in 2026?

Based on GuruFocus' analysis, Enzymatica AB stock appears to be overvalued. The current stock price of €0.20 is trading 24.4% above its estimated GF Value™ of €0.16.

Key valuation signals for STU:EN9:

FCF Margin %: -59.70%
GF Value™: €0.16 vs. price of €0.20 (24.4% above fair value)
GF Score™: 58/100 with 2 warning signs

No single metric tells the full story. See the STU:EN9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enzymatica AB Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies OSTO:ORX OSTO:EQL OSTO:CINPHA OSTO:NANEXA OSTO:MOB OSTO:DICOT OSTO:KLAR XSAT:ACUC OSTO:VIVE XSAT:ODI XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Other Exchanges ENZY:Sweden EN9:Germany

Address Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70

Website http://www.enzymatica.se

Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

58GF Score

Get the complete analysis for STU:EN9

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.20

Price

€0.16

GF Value

View STU:EN9 Analysis

See FCF Margin % data for all stocks →